UNSPSC 51334409: Fosenazide

This classification denotes an antipsychotic agent and antidepressant with the molecular formula C14H15N2O2P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 16C19Z7F4I, chemically known as (diphenylphosphinyl)acetic acid, hydrazide but generally known as fosenazide, which bears US NIH Compound Identifier 27918. European Medicines Agency schedules Fosenazide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07794MIG. The term FOSENAZIDE is an International Non-Proprietary Name.

UNSPSC 51334409 Fosenazide is a Commodity code that captures pharmaceutical and chemical products for public health and emergency response use. State and local governments procure under this code products such as naloxone (opioid-overdose reversal agents) and drug deactivation systems for community health initiatives, emergency medical response, and substance-abuse intervention programs. Issuing bodies include county health departments and public health agencies that support emergency preparedness and community wellness infrastructure.

Seminole County, Florida posted an IFB (IFB60459723LAS) in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023, for quarterly delivery to the Seminole County Community Health Building in Sanford. The contract carries a two-year initial term with a one-year renewal option, fixed-fee pricing, E-Verify and drug-free workplace compliance, and potential FEMA funding with associated federal environmental and audit requirements. The source reflects limited recent activity under this code; the single documented opportunity is the Seminole County procurement.